2019国际医学人工智能论坛在沪召开

4月1日,"2019国际医学人工智能论坛暨ITU与WHO健康医疗人工智能焦点组(AI4H)会议"在上海世博中心开幕.据悉,本次论坛以"人工智能赋能人类健康共同体"为主题,由世界卫生组织(WHO),国际电信联盟(ITU)指导,中国信息通信研究院,国家卫生健康国际交流与合作中心,上海市经济和信息化委员会,上海申康医院发展中心,北京航空航天大学主办,互联网医疗健康产业联盟,中国信息通信研究院华东分院,中国医疗器械行业协会,IMT-2020(5G)推进组,工业互联网产业联盟,上海精准医疗研究院,中国技术交易所,上海交大-斯坦福大学智能医疗联合实验室,浙江省医院协会,河南省医院协会承办.论坛邀请了国内外专家对医疗领域普遍关注的热门问题进行深入交流和探讨,共同分析医学人工智能发展现状与展望未来.

AI 赋能的虚实融合基因组学教学在医学生 精准医疗决策能力培养中的探索

Objective To explore the AI-empowered virtual-reality integrated Genomics teaching mode and enhance medical students' precision medicine decision-making capabilities. Methods From September 2023 to August 2024A total of 100 students majoring in Clinical Medicine in the class of 2022 at Chongqing Medical University were selected into the experimental group (taught with AI-empowered virtual-reality integrated teaching), while 100 students majoring in Clinical Medicine in the class of 2022 were selected into the control group (receiving traditional teaching). Evaluation was performed by comparing the accuracy of genetic test reports, Objective Structured Clinical Examination (OSCE) clinical decision-making scores, and questionnaire survey results between the two groups. Results The experimental group demonstrated significant superiority over the control group in genetic test report accuracy [treatment recommendation matching scores: (2.40± 1.07) vs (1.86±1.33)], OSCE clinical decision-making scores [protocol compliance scores: (28.68± 0.81) vs (27.92±1.30)], and satisfaction [confidence in clinical decision-making: (4.92±0.27) vs (4.5±0.50)] (all P<0.05). Conclusion The AI-empowered virtual-reality integrated Genomics teaching mode outperformed traditional teaching by leveraging "technology-driven practice and data-driven closed-loop feedback", effectively improving medical students' precision medicine decision-making capabilities. This approach provides a replicable framework for the digital transformation of medical education.

中医药防治肌少症的关键问题,诊治优势与研究模式探索

肌少症是一种与增龄相关的老年综合征,严重损害老年人的生命质量和身心健康.现代医学在药物研发和疾病防控过程中面临多重瓶颈,中医药在"整体观念""辨证论治""治未病"理念指导下,对于肌少症的临床防治显现出独特优势.但其效应机制欠清晰,标准化研究缺位,成果转化不足等问题制约了其临床应用.肌肉与骨骼并非独立运作,而是通过解剖关联,生理协同与病理交互构成"命运共同体","肌骨同治"理念应贯穿于肌少症防治全程.在骨健康的战略背景下,探索中医药防治肌少症的研究模式,包括融合中医整体观与现代精准医疗理念,构建"病证结合"风险预测模型,探索中西医多学科协作诊疗模式,筛选潜在病-证生物标志物,并借助系统药理学,人工智能,类器官模型等现代科技解析中医药疗效机制,优化干预方案.从理论整合到技术赋能的全链条创新路径,旨在将中医药"经验智慧"转化为可量化的科学证据,为肌少症的全周期管理提供具有中国特色的"精准化,智能化,协同化,系统化"解决方案,助力健康老龄化战略实施.